透析患者的超脂蛋白血症 (a) 和植物雌激素治疗:一篇综述
1Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Clinical therapeutics
|July 13, 2023
概括
植物性雌激素疗法有效降低了透析患者的脂蛋白 (a) [Lp(a) ]与超脂蛋白 (a). 这种方法提供了一个有前途的策略来管理Lp(a) 水平和相关并发症在这个人群中.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心血管医学 心血管医学
- 内分泌学 在内分泌学.
背景情况:
- 超脂蛋白血症 (a) 是在透析患者中常见且严重的并发症.
- 目前对透析患者的高脂蛋白质血症 (a) 的治疗策略有限.
- 在透析患者中,脂蛋白 (a) [Lp(a) ] 含量因衰变和合成增加而升高.
研究的目的:
- 审查透析患者中超脂蛋白血症 (a) 的临床意义.
- 调查植物雌激素治疗在这种人群中管理高脂蛋白质血症 (a) 的潜力.
主要方法:
- 对检查透析患者的植物雌激素治疗和超脂蛋白血症 (a) 的研究进行了全面的文献搜索.
- 分析了来自临床试验和观察性研究的数据.
主要成果:
- 在大多数涉及透析患者和患有超脂蛋白血症 (a) 的非尿血病个体的研究中,植物性雌激素显著降低了血清Lp(a) 水平.
- 植物性雌激素治疗没有影响正常血清Lp (a) 的个体的Lp (a) 水平.
- 植物雌激素对Lp的降脂作用 (a) 似乎与雌激素的效果相似.
结论:
- 鉴于透析患者中超脂蛋白血症 (a) 的高患病率,植物雌激素治疗是一个可行的选择.
- 植物性雌激素治疗可能有助于降低升高的Lp (a) 水平,并减轻透析患者的相关健康风险.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
43
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
43
Peritoneal Dialysis III: Nursing Management
50
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
50
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
44
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
44
Chronic Kidney Disease II: Clinical Manifestations
35
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
35
Nephrotic Syndrome I : Introduction
9
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
Hemodialysis II: Procedure and Complications
42
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
42


